Securities code: Shanghai Haohai Biological Technology Co.Ltd(688366) securities abbreviation: Shanghai Haohai Biological Technology Co.Ltd(688366) Announcement No.: 2022011 Shanghai Haohai Biological Technology Co.Ltd(688366)
Announcement on the resolution of the 33rd meeting of the Fourth Board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
1、 Meetings of the board of directors
Shanghai Haohai Biological Technology Co.Ltd(688366) (hereinafter referred to as “the company”) the 33rd meeting of the Fourth Board of directors (hereinafter referred to as “the meeting”) was held by means of communication on March 11, 2022. The notice of the meeting was sent to all directors of the company in writing on March 8, 2022. The meeting was presided over by Mr. Hou Yongtai, chairman of the board. There were 11 directors of the company and 11 actually participated in the meeting. The meeting was convened and held in accordance with the company law of the people’s Republic of China and other laws, regulations, normative documents and the relevant provisions of Shanghai Haohai Biological Technology Co.Ltd(688366) articles of association.
2、 Deliberations of the board meeting
After deliberation, the directors present at the meeting made the following resolutions:
1. The proposal on adjusting the first grant of the 2021 A-share restricted stock incentive plan was reviewed and approved
In view of the resignation of one proposed incentive object from the company and the disqualification of one proposed incentive object determined in the Shanghai Haohai Biological Technology Co.Ltd(688366) 2021 A-share restricted stock incentive plan (Draft) (hereinafter referred to as the “incentive plan (Draft)”, the board of directors of the company The first general meeting of shareholders in 2022 (hereinafter referred to as “the first general meeting of shareholders of 2022 incentive plan”) will adjust the number of incentive shares granted by 2021 and 2022 restricted shares (hereinafter referred to as “the first general meeting of shareholders of 2022 incentive plan”). After this adjustment, the number of people granted for the first time in the incentive plan is adjusted from 206 to 204, the number of restricted shares granted for the first time is adjusted from 1.45 million shares to 1.44 million shares, and the number of reserved shares is adjusted from 350000 shares to 360000 shares. The total number of restricted shares granted in the incentive plan remains unchanged at 1.8 million shares.
The adjusted incentive objects belong to the scope of incentive objects specified in the incentive plan (Draft) approved by the company’s first general meeting of shareholders in 2022. In addition to the above adjustments, other contents of the incentive plan are consistent with those deliberated and approved by the company’s first general meeting of shareholders in 2022.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Announcement of Shanghai Haohai Biological Technology Co.Ltd(688366) on adjusting matters related to the first grant of A-share restricted stock incentive plan in 2021 (Announcement No.: 2022013)
The independent directors of the company expressed their consent to the proposal.
Directors Hou Yongtai, Wu Jianying, Tang agile and Chen Yiyi, as the incentive objects granted by the company for the first time in the incentive plan, avoided voting on the proposal.
Voting results: 7 in favor, 0 against and 0 abstention.
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
2. The proposal on granting A-share restricted shares to the incentive objects of the 2021 A-share restricted stock incentive plan for the first time was deliberated and adopted
In accordance with the measures for the administration of equity incentive of listed companies, the company’s incentive plan (Draft) and the authorization of the company’s first general meeting in 2022, the board of Directors considers that the conditions for the first grant of Restricted Shares specified in the incentive plan have been met, and agrees to take March 11, 2022 as the first grant date, The 204 incentive objects were granted 1.44 million restricted shares for the first time, with the grant price of 95.00 yuan / share.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) The announcement of Shanghai Haohai Biological Technology Co.Ltd(688366) on granting A-share restricted shares to the incentive objects of 2021 A-share restricted stock incentive plan for the first time (Announcement No.: 2022014) disclosed.
The independent directors of the company expressed their independent opinions on this.
Directors Hou Yongtai, Wu Jianying, Tang agile and Chen Yiyi, as the incentive objects granted by the company for the first time in the incentive plan, avoided voting on the proposal.
Voting results: 7 in favor, 0 against and 0 abstention.
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
It is hereby announced.
Shanghai Haohai Biological Technology Co.Ltd(688366) board of directors
March 12, 2022
